Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ND8J
|
||||
Former ID |
DNC013745
|
||||
Drug Name |
(-)-(1S,1'R)-O,O-dimethylgrisbine hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551356] | ||
Structure |
Download2D MOL |
||||
Formula |
C39H47ClN2O6
|
||||
Canonical SMILES |
CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=<br />CC(=C(C=C6CCN5C)OC)OC)OC)OC)OC.Cl
|
||||
InChI |
1S/C39H46N2O6.ClH/c1-40-16-14-27-21-35(43-4)37(45-6)23-30(27)32(40)18-25-8-11-29(12-9-25)47-39-20-26(10-13-34(39)42-3)19-33-31-24-38(46-7)36(44-5)22-28(31)15-17-41(33)2;/h8-13,20-24,32-33H,14-19H2,1-7H3;1H/t32-,33+;/m1./s1
|
||||
InChIKey |
OEBMBMKSAQUFSL-VMXYRSAXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [551356] | |
Dopamine D1 receptor | Target Info | Inhibitor | [551356] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.